Patents Assigned to Adare Pharmaceuticals USA, Inc.
  • Biodegradable polymer microsphere compositions for parenteral administration
    Patent number: 12036323
    Abstract: Novel microsphere compositions for use in parenteral formulations are provided. The microspheres comprise a biodegradable polymer of a molecular weight greater than 10,000 daltons, an active therapeutic agent, and a cellulose-derived material such as ethyl cellulose, carboxymethyl cellulose, hydroxypropylmethyl cellulose, or sodium carboxymethyl cellulose. The microsphere compositions decreased deviation in mean microsphere diameter, improved drug entrapment, and improved microsphere stability.
    Type: Grant
    Filed: June 28, 2023
    Date of Patent: July 16, 2024
    Assignee: ADARE PHARMACEUTICALS USA, INC.
    Inventors: Nathan Dormer, Cory Berkland
  • Biodegradable polymer microsphere compositions for parenteral administration
    Patent number: 11723868
    Abstract: Novel microsphere compositions for use in parenteral formulations are provided. The microspheres comprise a biodegradable polymer of a molecular weight greater than 10,000 daltons, an active therapeutic agent, and a cellulose-derived material such as ethyl cellulose, carboxymethyl cellulose, hydroxypropylmethyl cellulose, or sodium carboxymethyl cellulose. The microsphere compositions decreased deviation in mean microsphere diameter, improved drug entrapment, and improved microsphere stability.
    Type: Grant
    Filed: November 24, 2020
    Date of Patent: August 15, 2023
    Assignee: Adare Pharmaceuticals USA, Inc.
    Inventors: Nathan Dormer, Cory Berkland
  • Sustained release particle formulations
    Patent number: 11576861
    Abstract: Particles for delivery of active ingredients formed from an active ingredient and a hydrophobic matrix, as well as methods for making such particles.
    Type: Grant
    Filed: August 16, 2019
    Date of Patent: February 14, 2023
    Assignee: ADARE PHARMACEUTICALS USA, INC.
    Inventors: Cory Berkland, Milind Singh
  • Taste masking drug formulations
    Patent number: 11026893
    Abstract: The present disclosure relates to a taste-masking microcapsule composition. The composition comprises a core portion encapsulated by a shell portion. The core portion comprises an active pharmaceutical ingredient (API) and one or more excipients. The shell portion comprises a hydrophobic matrix and a pH-responsive material. The microcapsule compositions prevent API release at the more neutral pH levels in the oral cavity, but upon exposure to pH levels of the stomach, the pH-responsive material becomes soluble thereby permitting release of the API.
    Type: Grant
    Filed: August 16, 2019
    Date of Patent: June 8, 2021
    Assignee: Adare Pharmaceuticals USA, Inc.
    Inventors: Cory Berkland, Milind Singh
  • Biodegradable polymer microsphere compositions for parenteral administration
    Patent number: 10874612
    Abstract: Novel microsphere compositions for use in parenteral formulations are provided. The microspheres comprise a biodegradable polymer of a molecular weight greater than 10,000 daltons, an active therapeutic agent, and a cellulose-derived material such as ethyl cellulose, carboxymethyl cellulose, hydroxypropylmethyl cellulose, or sodium carboxymethyl cellulose. The microsphere compositions decreased deviation in mean microsphere diameter, improved drug entrapment, and improved microsphere stability.
    Type: Grant
    Filed: October 26, 2018
    Date of Patent: December 29, 2020
    Assignee: Adare Pharmaceuticals USA, Inc.
    Inventors: Nathan Dormer, Cory Berkland